Background: Alzheimer’s Disease (AD) is one of the most common causes of dementia, imposing large financial and psychological burdens on nations worldwide. Thus, we are in dire need for new treatment strategies or drugs for this disease. The aim of this study is to investigate the effects of a novel non-pharmacological method in the treatment of Alzheimer’s disease, based on Taheri’s Consciousness Fields approach. This approach works at the level of cellular and molecular processes. In this study the effects of Faradarmani Consciousness Field (FCF) on AD mouse model (in vivo) and human neuron cell line in vitro was investigated.
Methods: In this study, we established a human neuron cell culture as well as a traumatic brain injury (TBI) mouse model. We then measured changes in amyloidopathy, tau protein content, microtubule assembly, neuronal cell survival, and finally behavior of TBI mice in elevated Plus Maze under treatment of the FCF.
Results: According to the results of this study, treatment of human neural cell and mouse model of Alzheimer’s disease by the FCF, leads to about complete survival of neural cell models and elimination of amyloidopathy and tau protein and remarkable behavioral improvement of the treated TBI mice model in the elevated plus maze.
Conclusions: Based on the results, the FCF treatment suppresses AD development in the laboratory models. In this regard, conducting a human clinical study with the aim of introducing a new global complementary and alternative medicine in AD treatment is highly recommended.
Keywords: Alzheimer’s Disease; Faradarmani Consciousness Field; TBI; mice model; neural cell model